Acurx Pharmaceuticals, Inc. (ACXP) had a big price jump after the following news:
Acurx Pharmaceuticals Announces Successful Completion and Early Discontinuation of the Ibezapolstat Phase 2b Trial for Treatment of C. difficile Infection :: Acurx Pharmaceuticals, Inc. (ACXP)
It seems the market believe in the story of Acurx. How big is the competition for Recce here?
x
Acurx Pharmaceuticals
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
-0.015(2.52%) |
Mkt cap ! $120.3M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 59.5¢ | 58.0¢ | $7.271K | 12.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 37974 | 58.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 700 | 3 |
View Market Depth
| Last trade - 13.05pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
58.0¢ |
Change
-0.015 ( 0.85 %) |
||||
| Open | High | Low | Volume | ||
| 58.0¢ | 58.0¢ | 58.0¢ | 2500 | ||
| Last updated 12.58pm 05/06/2024 ? | |||||
| RCE (ASX) Chart |